We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Charles River Laboratories International Inc | NYSE:CRL | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
3.58 | 1.56% | 233.47 | 238.38 | 232.18 | 233.61 | 466,193 | 01:00:00 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
Molho Davide |
2. Issuer Name
and
Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL INC [ CRL ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) Corporate Executive VP |
251 BALLARDVALE STREET |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
WILMINGTON, MA 01887 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 9/5/2017 | S | 200 | D | $107.93 | 24906 | D | |||
Common Stock | 9/5/2017 | S | 200 | D | $107.945 | 24706 | D | |||
Common Stock | 9/5/2017 | S | 300 | D | $107.97 | 24406 | D | |||
Common Stock | 9/5/2017 | S | 90 | D | $107.98 | 24316 | D | |||
Common Stock | 9/5/2017 | S | 300 | D | $107.985 | 24016 | D | |||
Common Stock | 9/5/2017 | S | 200 | D | $107.99 | 23816 | D | |||
Common Stock | 9/5/2017 | S | 10 | D | $107.995 | 23806 | D | |||
Common Stock | 9/5/2017 | S | 300 | D | $108.00 | 23506 | D | |||
Common Stock | 9/5/2017 | S | 100 | D | $108.005 | 23406 | D | |||
Common Stock | 9/5/2017 | S | 210 | D | $108.01 | 23196 | D | |||
Common Stock | 9/5/2017 | S | 207 | D | $108.02 | 22989 | D | |||
Common Stock | 9/5/2017 | S | 100 | D | $108.025 | 22889 | D | |||
Common Stock | 9/5/2017 | S | 500 | D | $108.03 | 22389 | D | |||
Common Stock | 9/5/2017 | S | 22 | D | $108.04 | 22367 | D | |||
Common Stock | 9/5/2017 | S | 100 | D | $108.055 | 22267 | D | |||
Common Stock | 9/5/2017 | S | 1104 | D | $108.06 | 21163 | D | |||
Common Stock | 9/5/2017 | S | 200 | D | $108.065 | 20963 | D | |||
Common Stock | 9/5/2017 | S | 100 | D | $108.075 | 20863 | D | |||
Common Stock | 9/5/2017 | S | 500 | D | $108.09 | 20363 | D | |||
Common Stock | 9/5/2017 | S | 100 | D | $108.10 | 20263 | D | |||
Common Stock | 9/5/2017 | S | 6 | D | $108.105 | 20257 | D | |||
Common Stock | 9/5/2017 | S | 100 | D | $108.11 | 20157 | D | |||
Common Stock | 9/5/2017 | S | 100 | D | $108.12 | 20057 | D | |||
Common Stock | 9/5/2017 | S | 4 | D | $108.125 | 20053 | D | |||
Common Stock | 9/5/2017 | S | 36 | D | $108.13 | 20017 | D | |||
Common Stock | 9/5/2017 | S | 200 | D | $108.16 | 19817 | D | |||
Common Stock | 9/5/2017 | S | 100 | D | $108.18 | 19717 | D | |||
Common Stock | 9/5/2017 | S | 200 | D | $108.24 | 19517 | D | |||
Common Stock | 9/5/2017 | S | 300 | D | $108.26 | 19217 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Molho Davide
251 BALLARDVALE STREET WILMINGTON, MA 01887 |
|
|
Corporate Executive VP |
|
Signatures
|
||
/s/ Davide A. Molho | 9/6/2017 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Charles River Laboratories Chart |
1 Month Charles River Laboratories Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions